Matches in Nanopublications for { ?s ?p "[TM-1 administered (10 mg/kg, intraperitoneal injection) at 3 or 4 h after TBI significantly reduced the elevated mRNA expression and protein levels of AQP1 and AQP4 and diminished the wet/dry weight ratio, which reflects PE, in the lung at 8 and 24 h after TBI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP1265657.RAv5UZlHlD8RT0v-GqChB_R_JP0zQAAKKZpW4mkmTg6QM130_assertion description "[TM-1 administered (10 mg/kg, intraperitoneal injection) at 3 or 4 h after TBI significantly reduced the elevated mRNA expression and protein levels of AQP1 and AQP4 and diminished the wet/dry weight ratio, which reflects PE, in the lung at 8 and 24 h after TBI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1265657.RAv5UZlHlD8RT0v-GqChB_R_JP0zQAAKKZpW4mkmTg6QM130_provenance.
- NP1265658.RA2CQ4sk3-Kim_DIfUQfyanCycjWbmLSOx2oJEH4wpsfU130_assertion description "[TM-1 administered (10 mg/kg, intraperitoneal injection) at 3 or 4 h after TBI significantly reduced the elevated mRNA expression and protein levels of AQP1 and AQP4 and diminished the wet/dry weight ratio, which reflects PE, in the lung at 8 and 24 h after TBI.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1265658.RA2CQ4sk3-Kim_DIfUQfyanCycjWbmLSOx2oJEH4wpsfU130_provenance.